The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Becton, Dickinson and Co

NYSE: BDX
Last

(U.S.) $138.00

Today's change-3.02 -2.14%
Updated September 1 9:49 AM EDT. Delayed by at least 15 minutes.
 

Becton, Dickinson and Co

NYSE: BDX
Last

(U.S.) $138.00

Today's change-3.02 -2.14%
Updated September 1 9:49 AM EDT. Delayed by at least 15 minutes.

Becton, Dickinson and Co down (U.S.)$3.02

Becton, Dickinson and Co is sharply lower today, dropping (U.S.)$3.02 or 2.14% to (U.S.)$138.00. Over the last five days, shares have gained 0.28%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 20.95% during the last year.

Key company metrics

  • Open(U.S.) $138.50
  • Previous close(U.S.) $141.02
  • High(U.S.) $139.23
  • Low(U.S.) $137.69
  • Bid / Ask(U.S.) $137.95 / (U.S.) $138.01
  • YTD % change-0.83%
  • Volume116,572
  • Average volume (10-day)1,566,393
  • Average volume (1-month)1,342,311
  • Average volume (3-month)1,108,690
  • 52-week range(U.S.) $112.15 to (U.S.) $154.98
  • Beta0.98
  • Trailing P/E33.73×
  • P/E 1 year forward19.84×
  • Forward PEG1.52×
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield1.74%
  • Trailing EPS(U.S.) $4.09
Updated September 1 9:49 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.64%

Based on its net profit margin of 8.64%, Becton, Dickinson and Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.84%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue3,1202,0512,0512,202
Total other revenue--------
Total revenue3,1202,0512,0512,202
Gross profit1,1881,0461,0451,102
Total cost of revenue1,9321,0051,0061,100
Total operating expense2,9831,7581,7021,801
Selling / general / administrative764511544561
Research & development178129129140
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)10811323--
Other operating expenses, total1------
Operating income137293349401
Interest income (expense), net non-operating-105-91-76-36
Gain (loss) on sale of assets--------
Other--------
Income before tax39225285377
Income after tax62216235301
Income tax, total-2395076
Net income62216235301
Total adjustments to net income----1--
Net income before extra. items62216235301
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items62216236301
Inc. avail. to common incl. extra. items62216236301
Diluted net income62216236301
Dilution adjustment----0--
Diluted weighted average shares215200197197
Diluted EPS excluding extraordinary itemsvalue per share0.291.081.201.52
Dividends per sharevalue per share0.600.600.600.55
Diluted normalized EPSvalue per share0.621.621.291.52